| Literature DB >> 30235178 |
Zhongyang Gao1,2, Fenggang Ren3, Hui Song1, Yiqun Wang1, Yibin Wang1, Zhengchao Gao1, Junjie Zhu2, Xijing He1.
Abstract
BACKGROUND Previous studies have shown that differences in marital status contribute to different prognoses for certain cancers, but the relationship between marital status and the prognosis of chondrosarcoma has not been reported previously. MATERIAL AND METHODS In this study, we selected 4502 eligible cases through the Surveillance, Epidemiology, and End Results (SEER) database from 1977 to 2014 to analyze the impact of marital status on chondrosarcoma cancer-specific survival (CSS) by Kaplan-Meier method and Cox regression model. RESULTS The sex, age, histotype, pathological grade, tumor location, tumor size, SEER stage, socioeconomic status, marital status, and treatment were identified as independent prognostic factors for chondrosarcoma CSS. Widowed patients presented the worst CSS compared with their married, divorced, and single counterparts (P<0.001). Subgroup analyses showed widowed patients also had a significantly higher risk of cancer-specific mortality compared with married patients in localized stage (HR: 1.971, 95% CI: 1.298-2.994, P=0.001), regional stage (HR: 1.535, 95% CI: 1.094-2.154, P=0.013), low pathological grade (HR: 1.866, 95% CI: 1.332-2.613, P<0.001), and high pathological grade (HR: 1.662, 95% CI: 1.139-2.426, P=0.008). CONCLUSIONS Marital status was first identified as an independent prognostic factor for chondrosarcoma CSS, and widowhood was always associated with a high risk of cancer-specific mortality. It is necessary to provide timely psychological treatment for widowed patients in clinical practice, which can improve the survival of chondrosarcoma patients.Entities:
Mesh:
Year: 2018 PMID: 30235178 PMCID: PMC6161567 DOI: 10.12659/MSM.911673
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Baseline demographics and clinicopathological characteristics of chondrosarcoma patients in SEER database.
| Characteristic | Total | Married | Divorced | Single | Widowed | P value |
|---|---|---|---|---|---|---|
| n=4502 | n=2830 | n=392 | n=975 | n=305 | ||
| Sex | <0.001 | |||||
| Male | 2510 | 1678 (59.3%) | 183 (46.7%) | 577 (59.2%) | 72 (23.6%) | |
| Female | 1992 | 1152 (40.7%) | 209 (53.3%) | 398 (40.8%) | 233 (76.4%) | |
| Age | <0.001 | |||||
| <60 | 2965 | 1827 (64.6%) | 263 (67.1%) | 837 (85.8%) | 38 (12.5%) | |
| ≥60 | 1537 | 1003 (35.4%) | 129 (32.9%) | 138 (14.2%) | 267 (87.5%) | |
| Race | <0.001 | |||||
| White | 3949 | 2543 (89.9%) | 344 (87.8%) | 792 (81.2%) | 270 (88.5%) | |
| Black | 315 | 137 (4.8%) | 33 (8.4%) | 126 (12.9%) | 19 (6.2%) | |
| Other | 238 | 150 (5.3%) | 15 (3.8%) | 57 (5.9%) | 16 (5.3%) | |
| Histotype | <0.001 | |||||
| Chondrosarcoma, NOS | 3483 | 2191 (77.4%) | 315 (80.4%) | 746 (76.5%) | 234 (76.7%) | |
| Myxoid | 561 | 378 (13.4%) | 42 (10.7%) | 106 (10.9%) | 35 (11.5%) | |
| Mesenchymal | 158 | 80 (2.8%) | 8 (2.0%) | 63 (6.5%) | 7 (2.3%) | |
| Dedifferentiated | 195 | 124 (4.4%) | 19 (4.9%) | 25 (2.6%) | 27 (8.9%) | |
| Other | 102 | 57 (2.0%) | 8 (2.0%) | 35 (3.5%) | 2 (0.6%) | |
| Pathological grade | 0.064 | |||||
| Low-grade | 2985 | 1903 (67.2%) | 259 (66.1%) | 645 (66.2%) | 178 (58.4%) | |
| High-grade | 689 | 420 (14.8%) | 66 (16.8%) | 142 (14.6%) | 61 (20.0%) | |
| Unknown | 828 | 507 (18.0%) | 67 (17.1%) | 188 (19.2%) | 66 (21.6%) | |
| Tumor location | 0.170 | |||||
| Extremities | 1904 | 1173 (41.4%) | 176 (44.9%) | 406 (41.6%) | 149 (48.9%) | |
| Axial | 1413 | 910 (32.2%) | 117 (29.8%) | 309 (31.7) | 77 (25.2%) | |
| Other | 1185 | 747 (26.4%) | 99 (25.3%) | 260 (26.7%) | 79 (25.9%) | |
| Tumor size | 0.058 | |||||
| <8 cm | 1892 | 1211 (42.8%) | 169 (43.1%) | 410 (42.1%) | 102 (33.4%) | |
| ≥8 cm | 1226 | 747 (26.4%) | 106 (27.0%) | 280 (28.7%) | 93 (30.5%) | |
| Unknown | 1384 | 872 (30.8%) | 117 (29.9%) | 285 (29.2%) | 110 (36.1%) | |
| SEER stage | 0.003 | |||||
| Localized | 2272 | 1465 (51.8%) | 206 (52.6%) | 485 (49.7%) | 116 (38.0%) | |
| Regional | 1492 | 903 (31.9%) | 130 (33.2%) | 335 (34.4%) | 124 (40.6%) | |
| Distant | 413 | 262 (9.3%) | 33 (8.4%) | 85 (8.7%) | 33 (10.9%) | |
| Unstaged | 325 | 200 (7.0%) | 23 (5.8%) | 70 (7.2%) | 32 (10.5%) | |
| Socioeconomic status | 0.002 | |||||
| Low-SES | 2275 | 1367 (48.3%) | 210 (53.6%) | 533 (55.6%) | 165 (54.1%) | |
| High-SES | 2227 | 1463 (51.7%) | 182 (46.4%) | 442 (43.3%) | 140 (45.9%) | |
| Treatment | <0.001 | |||||
| Surgery and radiation | 650 | 404 (14.3%) | 54 (13.8%) | 144 (14.8%) | 48 (15.7%) | |
| Only surgery | 3385 | 2164 (76.4%) | 299 (76.3%) | 724 (74.2%) | 198 (64.9%) | |
| Only radiation | 141 | 78 (2.8%) | 15 (3.8%) | 26 (2.7%) | 22 (7.3%) | |
| None | 326 | 184 (6.5%) | 24 (6.1%) | 81 (8.3%) | 37 (12.1%) | |
| Cancer-specific death | <0.001 | |||||
| Events | 1046 | 638 (22.5%) | 99 (25.3%) | 192 (19.7%) | 117 (38.4%) | |
| Censored | 3456 | 2192 (77.5%) | 293 (74.7%) | 783 (80.3%) | 188 (61.6%) |
SEER – Surveillance, Epidemiology, and End Results; NOS – not otherwise specified; SES – socioeconomic status.
Univariate and multivariate survival analysis for evaluating the effect of marital status on chondrosarcoma CSS in SEER database.
| Variable | 5-year CSS | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Log rank χ2 test | P | HR (95% CI) | P | ||
| Sex | 37.283 | <0.001 | |||
| Male | 76.9% | Reference | |||
| Female | 83.3% | 0.659 (0.577–0.753) | <0.001 | ||
| Age | 189.183 | <0.001 | |||
| <60 | 85.1% | Reference | |||
| ≥60 | 69.0% | 1.743 (1.520–1.998) | <0.001 | ||
| Race | 1.452 | 0.484 | NI | ||
| White | 79.7% | ||||
| Black | 79.2% | ||||
| Other | 80.6% | ||||
| Histotype | 576.205 | <0.001 | |||
| Chondrosarcoma, NOS | 83.3% | Reference | |||
| Myxoid | 79.0% | 0.989 (0.806–1.214) | 0.919 | ||
| Mesenchymal | 51.9% | 2.031 (1.560–2.644) | <0.001 | ||
| Dedifferentiated | 28.1% | 2.376 (1.892–2.984) | <0.001 | ||
| Other | 91.9% | 0.524 (0.280–0.983) | 0.044 | ||
| Pathological grade | 621.672 | <0.001 | |||
| Low-grade | 88.5% | Reference | |||
| High-grade | 50.6% | 2.719 (2.300–3.215) | <0.001 | ||
| Unknown | 71.4% | 1.845 (1.563–2.179) | <0.001 | ||
| Tumor location | 40.407 | <0.001 | |||
| Extremities | 82.6% | Reference | |||
| Axial | 74.6% | 1.176 (1.015–1.362) | 0.031 | ||
| Other | 81.1% | 0.760 (0.631–0.915) | 0.004 | ||
| Tumor size | 195.597 | <0.001 | |||
| <8 cm | 87.7% | Reference | |||
| ≥8 cm | 67.8% | 1.594 (1.353–1.879) | <0.001 | ||
| Unknown | 79.0% | 1.474 (1.245–1.745) | <0.001 | ||
| SEER stage | 1006.710 | <0.001 | |||
| Localized | 90.2% | Reference | |||
| Regional | 76.0% | 1.930 (1.647–2.263) | <0.001 | ||
| Distant | 35.4% | 4.847 (4.011–5.856) | <0.001 | ||
| Unstaged | 79.1% | 1.460 (1.119–1.904) | 0.005 | ||
| Socioeconomic status | 11.734 | 0.001 | |||
| Low-SES | 77.6% | Reference | |||
| High-SES | 81.9% | 0.863 (0.762–0.978) | 0.021 | ||
| Marital status | 67.442 | <0.001 | |||
| Married | 80.3% | Reference | |||
| Divorced | 78.4% | 1.367 (1.103–1.693) | 0.004 | ||
| Single | 84.0% | 0.892 (0.754–1.056) | 0.185 | ||
| Widowed | 62.3% | 1.516 (1.222–1.880) | <0.001 | ||
| Treatment | 625.543 | <0.001 | |||
| Surgery and radiation | 71.6% | Reference | |||
| Only surgery | 85.2% | 0.661 (0.560–0.780) | <0.001 | ||
| Only radiation | 23.3% | 2.264 (1.755–2.921) | <0.001 | ||
| None | 60.0% | 1.461 (1.155–1.848) | 0.002 | ||
SEER – Surveillance, Epidemiology, and End Results; CSS – cancer-specific survival; HR – hazard ratio; CI – confidence interval; NOS – not otherwise specified; SES – socioeconomic status; NI – not included in the multivariate survival analysis.
Figure 1Survival curves of chondrosarcoma patients according to marital status (married, divorced, single, and widowed). χ2=67.442, P<0.001.
Univariate and multivariate survival analysis for marital status on chondrosarcoma cause-specific survival based on different SEER stages.
| SEER stage | 5-year CSS | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Log rank χ2 test | P | HR (95% CI) | P | ||
| Localized | 42.533 | <0.001 | |||
| Married | 90.1% | Reference | |||
| Divorced | 91.2% | 1.203 (0.797–1.815) | 0.380 | ||
| Single | 94.2% | 0.807 (0.560–1.162) | 0.249 | ||
| Widowed | 69.8% | 1.971 (1.298–2.994) | 0.001 | ||
| Regional | 15.934 | 0.001 | |||
| Married | 76.6% | Reference | |||
| Divorced | 70.7% | 1.440 (1.034–2.007) | 0.031 | ||
| Single | 80.7% | 1.047 (0.811–1.351) | 0.724 | ||
| Widowed | 64.3% | 1.535 (1.094–2.154) | 0.013 | ||
| Distant | 9.443 | 0.024 | |||
| Married | 37.3% | Reference | |||
| Divorced | 20.1% | 1.396 (0.901–2.162) | 0.135 | ||
| Single | 36.2% | 0.745 (0.539–1.031) | 0.076 | ||
| Widowed | 14.0% | 1.270 (0.834–1.932) | 0.265 | ||
SEER – Surveillance, Epidemiology, and End Results; CSS – cancer-specific survival; HR – hazard ratio; CI – confidence interval.
Figure 2Survival curves of chondrosarcoma patients according to marital status in different SEER stages. (A) localized stage: χ2=42.533, P<0.001; (B) regional stage: χ2=15.934, P= 0.001; (C) distant stage: χ2=9.443, P=0.024.
Univariate and multivariate survival analysis for marital status on chondrosarcoma cause-specific survival based on different pathological grades.
| Pathological grade | 5-year CSS | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Log rank χ2 test | P | HR (95% CI) | P | ||
| Low-grade | 44.649 | <0.001 | |||
| Married | 89.1% | Reference | |||
| Divorced | 87.3% | 1.527 (1.111–2.100) | 0.009 | ||
| Single | 91.6% | 1.043 (0.803–1.354) | 0.751 | ||
| Widowed | 71.5% | 1.866 (1.332–2.613) | <0.001 | ||
| High-grade | 15.492 | 0.001 | |||
| Married | 51.8% | Reference | |||
| Divorced | 47.4% | 1.236 (0.840–1.817) | 0.282 | ||
| Single | 55.0% | 0.938 (0.689–1.276) | 0.682 | ||
| Widowed | 26.6% | 1.662 (1.139–2.426) | 0.008 | ||
CSS – cancer-specific survival; HR – hazard ratio; CI – confidence interval.
Figure 3Survival curves of chondrosarcoma patients according to marital status in different grades. (A) low-grade: χ2=44.649, P<0.001; (B) high-grade: χ2=15.492, P=0.001.